increased circulating creatinine level_Fah<tm1Mgo>/Fah<tm1Mgo>

http://metadb.riken.jp/0005553EI129S7SvEvBrdorI129S7SvEvBrdC57BL6JFahtm1MgoFahtm1MgoFahtm1Mgo

increased circulating creatinine level_Fah<tm1Mgo>/Fah<tm1Mgo>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• fumarylacetoacetate hydrolase
  http://metadb.riken.jp/db/mgi_rdf/MGI:95482

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Fah<tm1Mgo>/Fah<tm1Mgo>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Fah<tm1Mgo>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J)

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased circulating creatinine level
  http://purl.obolibrary.org/obo/MP_0005553

文献

http://purl.org/net/cito/citesAsAuthority

• M. Grompe, et.al., Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice., Genes & development, 1993, 7
  http://rdf.ncbi.nlm.nih.gov/pubmed/8253378